MICHAEL VOLK to Hepatitis C, Chronic
This is a "connection" page, showing publications MICHAEL VOLK has written about Hepatitis C, Chronic.
Connection Strength
1.103
-
Trends in hepatitis C treatment uptake in the United States. Hepatology. 2014 Aug; 60(2):768-9.
Score: 0.317
-
Improving screening for hepatocellular carcinoma by incorporating data on levels of a-fetoprotein, over time. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):437-40.
Score: 0.285
-
Antiviral therapy for hepatitis C: why are so few patients being treated? J Antimicrob Chemother. 2010 Jul; 65(7):1327-9.
Score: 0.238
-
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1.
Score: 0.109
-
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2017 05; 101(5):1001-1008.
Score: 0.096
-
A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clin Gastroenterol Hepatol. 2010 Mar; 8(3):280-8, 288.e1.
Score: 0.058